No stockholder action required at this timeSan Diego, California--(Newsfile Corp. - June 27, 2025) - The Special Committee of the Board of Directors (the "Special Committee") of Sonim Technologies, Inc. (NASDAQ: SONM), formed to oversee the Company's ongoing strategic alternatives process, today confirmed receipt of an unsolicited, non-binding proposal from Orbic North America, LLC to acquire substantially all of Sonim's operating assets for $25 million. The proposal, dated June 26, 2025, represented that ...

I focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ...

小米YU7上市表现 - 小米新电动SUV YU7在发布一小时内获得近30万订单，直接对标特斯拉Model Y [1] - YU7中国定价3.5万美元，较Model Y的3.676万美元起售价更具价格优势 [1] - 小米CEO雷军公开表示将与特斯拉正面竞争，强调产品力和本土市场热情 [2] 小米的竞争策略与优势 - 小米构建集成化数字生态系统，将汽车视为联网设备终端，契合中国数字经济特点 [4] - 全球超6亿小米智能设备用户基础，可能形成比传统车企更强的客户黏性 [5] - 首款车型SU7获行业好评，被评价"不像初入车企的产品"，展现技术实力 [5] 特斯拉在华困境 - 2025年1-5月特斯拉中国纯电车型销量同比下滑18%，同期比亚迪全球销量超特斯拉29.1万辆 [9] - 比亚迪2024年全球营收1070亿美元超越特斯拉的977亿美元 [9] - 4月比亚迪在欧洲市场首次以7,230辆销量超越特斯拉的7,165辆 [10] 产品与运营挑战 - 分析师指出Model Y车型老化问题突出，但特斯拉暂无全新换代计划 [10] - 制造副总裁Omead Afshar和Optimus项目负责人Milan Kovac相继离职，反映内部压力 [11] - 特斯拉软件创新优势被削弱，缺乏符合中国市场的本地化数字生态整合 [13][14] 行业竞争格局 - 行业分析师认为小米是特斯拉迄今最大威胁，其竞争力可能影响全球市场 [3] - 中国市场价格战激烈，竞争对手在规格和电池性能上快速追赶 [10] - 特斯拉仍保有电动车先驱声誉，但需应对日益复杂的竞争环境 [12][13]

U.S. Border Patrol and protesters clash after a raid was conducted by Immigration and Customs Enforcement near a Home Depot on June 7, 2025 in Paramount, California. Around 30 agents wearing tactical gear were stationed near a Home Depot in Paramount and faced off against protesters, south of downtown Los Angeles.Home improvement store parking lots were once teeming with aspiring laborers looking for a day's work.  Contractors needing temporary help would swing by and scoop up a few workers for the day, and ...

MOUNTAIN VIEW, Calif., June 27, 2025 /PRNewswire/ -- Cyngn Inc. (NASDAQ: CYN) today announced the closing of a registered direct offering with a single institutional investor for the purchase and sale of approximately $15.0 million of shares of Common Stock and pre-funded warrants at a price of $5.01 per share of Common Stock.The offering consisted of the sale of 2,994,012 shares of Common Stock (or Pre-Funded Warrants. The public offering price per share of Common Stock was $5.01 (or $5.00999 for each Pre- ...

COLUMBUS, Ga., June 27, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release second quarter 2025 financial results after the market closes on Tuesday, August 5, 2025. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be available, along with a financial update video from Senior Executive Vice President and Chief Financial Officer Max Brodén, on the company's Investor Relations website, investors.aflac.com.Aflac Incor ...

Here's our initial take on Nike's (NKE 15.77%) fiscal 2025 fourth-quarter financial report.Key MetricsMetricQ4 FY24Q4 FY25Changevs. ExpectationsRevenue$12.6 billion$11.1 billion-12%BeatEarnings per share (adjusted)$1.01$0.14-86%BeatNIKE Direct revenue$5.1 billion$4.4 billion-14%n/aGross margin44.7%40.3%-4.4 ppn/aA Rough Quarter for NikeNike beat analyst expectations with its fiscal fourth-quarter results, but the bar was low. Total revenue tumbled 12% year over year, and adjusted earnings per share were dow ...

Key Takeaways ADMA posted $114.8M in Q1 revenues, driven by record Asceniv sales. The new process ups IG output by 20%, supporting ADMA's $500M revenue target for 2025. Despite gains, ADMA trades at 7.68x sales and faces EPS estimate cuts amid stiff plasma therapy competition. ADMA Biologics (ADMA) markets plasma-derived biologics for the treatment of immune deficiencies and prevention of certain infectious diseases.ADMA’s lead product, Asceniv, is a plasma-derived Intravenous Immune Globulin that contain ...

Have you looked into ESG high-yield investing? Environmental, Social, and Governance issues have made some inroads in the market over the past few years. You're likely to see an ESG section in companies' financial reports that lays out their records on theseWith Hidden Dividend Stocks Plus he scours the world's markets to find solid income opportunities with dividend yields ranging from 5% to 10% or more, backed by strong earnings. Features include: a portfolio with up to 40 holdings at a time including lin ...

FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”). The Reverse Stock Split is intended to increase the market price per share of the Company’s Common Stock and help the Company satisfy the initial listing requirements of t ...